These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7400 related articles for article (PubMed ID: 2757668)

  • 1. Stability in biological fluids and clearance of immunoliposomes.
    Weckenmann HP; Matzku S; Stricker H; Sinn H
    Arzneimittelforschung; 1989 Mar; 39(3):415-20. PubMed ID: 2757668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of the covalent binding of monoclonal antibodies to liposomes.
    Weckenmann HP; Matzku S; Stricker H
    Arzneimittelforschung; 1988 Nov; 38(11):1556-63. PubMed ID: 3214439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
    Kirpotin DB; Drummond DC; Shao Y; Shalaby MR; Hong K; Nielsen UB; Marks JD; Benz CC; Park JW
    Cancer Res; 2006 Jul; 66(13):6732-40. PubMed ID: 16818648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S; Igarashi S; Honda A; Sato S; Hanai N
    Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors of elimination of liposome-encapsulated drug model substances after intravenous administration].
    Kibat P; Stricker H
    Arzneimittelforschung; 1988 Oct; 38(10):1472-8. PubMed ID: 3196388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of immunoliposomes for targeting of antiviral agents.
    Kalvakolanu DV; Abraham A
    Biotechniques; 1991 Aug; 11(2):218-22, 224-5. PubMed ID: 1931020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
    Sroda K; Rydlewski J; Langner M; Kozubek A; Grzybek M; Sikorski AF
    Cell Mol Biol Lett; 2005; 10(1):37-47. PubMed ID: 15809678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
    Mougin-Degraef M; Bourdeau C; Jestin E; Saï-Maurel C; Bourgeois M; Saëc PR; Thédrez P; Gestin JF; Barbet J; Faivre-Chauvet A
    Int J Pharm; 2007 Nov; 344(1-2):110-7. PubMed ID: 17592745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
    Bao A; Goins B; Klipper R; Negrete G; Phillips WT
    J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody covalently coupled to liposomes: specific targeting to cells.
    Barbet J; Machy P; Leserman LD
    J Supramol Struct Cell Biochem; 1981; 16(3):243-58. PubMed ID: 7031274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug transfer into lymphoblasts mediated by liposomes bound to distinct sites on H-2 encoded I-A, I-E, and K molecules.
    Machy P; Pierres M; Barbet J; Leserman LD
    J Immunol; 1982 Nov; 129(5):2098-102. PubMed ID: 6811657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodies.
    Keep PA; Searle F; Begent RH; Barratt GM; Boden J; Bagshawe KD; Ryman BE
    Oncodev Biol Med; 1983; 4(4):273-80. PubMed ID: 6601263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 370.